Libero Pharma Limited
- Biotech or pharma, therapeutic R&D
Libero Pharma is leveraging the FDA’s 505(b)(2) pathway to create naltrexone patches, offering novel treatments for Opiate Use Disorder, Alcohol Use Disorder, Fibromyalgia, and Crohn’s Disease.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}